View abstract

This abstract is assigned to session AOB Free Papers

Presentation type	Oral presentation
Title	Ruthenium Brachytherapy in eye tumors

Purpose	Between 2019 and 2013, 214 applications with Ruthenium brachytherapy in Leuven University Hospital. This study audits the indications, results, and the rates of local and distal metastases.
Methods	Retrospective study
Results	Of 214 applications, 25 were conjunctival melanomas, 11 squamous cell carcinomas, 3 metastases, 2 hemangiomas, and 1 sacroma. The other 172 were uveal melanomas. Different sizes of plaques were used: 92 CCA, 91 CCB, 26 COB (for juxtapapillary tumors) and 5 CCC. 111 right eyes, and 100 males. Mean age at diagnosis was 66 years.
Conclusion	Ruthenium brachytherapy is a good and safe treatment for uveal and conjunctival melanomas, and can be very effective voor squamous cell carcinomas, large hemangiomas and metastases.
Conflict of interest	No

Authors 1

Last name	MISSOTTEN
Initials	G
Department	Jessa Oogkliniek Hasselt and University Hospitals Leuven
City	Hasselt/Leuven

Authors 2

Last name	Van Calster
Initials	J
Department	Leuven University Hospitals
City	Leuven